{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:32:12Z","timestamp":1793035932307,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jim.2025.113905","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:43:00Z","timestamp":1752680580000},"page":"113905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An in-silico-designed multiepitope vaccine candidate can efficiently protect mice against pathogenic species of Shigella"],"prefix":"10.1016","volume":"542","author":[{"given":"Amir Namvar","family":"Vansofla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hajizade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousof","family":"Tarverdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad","family":"Shahmaleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/infdis\/171.2.447","article-title":"Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992","volume":"171","author":"Arankalle","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jim.2025.113905_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/2051013613500428","article-title":"An update on vaccines against Shigella","volume":"1","author":"Ashkenazi","year":"2013","journal-title":"Ther Adv Vaccines."},{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.29252\/JABR.05.02.06","article-title":"Investigating the prevalence of Shigella species and their antibiotic resistance pattern in children with acute diarrhea referred to selected hospitals in Tehran, Iran","volume":"5","author":"Avakh Majalan","year":"2018","journal-title":"J Appl Biotechnol Rep."},{"key":"10.1016\/j.jim.2025.113905_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.aca.2013.05.043","article-title":"A rapid method for the detection of foodborne pathogens by extraction of a trace amount of DNA from raw milk based on amino-modified silica-coated magnetic nanoparticles and polymerase chain reaction","volume":"787","author":"Bai","year":"2013","journal-title":"Anal. Chim. Acta"},{"issue":"6","key":"10.1016\/j.jim.2025.113905_bb0025","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.vaccine.2009.11.001","article-title":"Characterization of WRSs2 and WRSs3, new second-generation virG (icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity","volume":"28","author":"Barnoy","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jim.2025.113905_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2023.105100","article-title":"A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice","volume":"25","author":"Bhaumik","year":"2023","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1651-2227.1999.tb01075.x","article-title":"Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis","volume":"88","author":"Chakrabarti","year":"1999","journal-title":"Acta Paediatr."},{"issue":"17","key":"10.1016\/j.jim.2025.113905_bb0040","doi-asserted-by":"crossref","first-page":"9871","DOI":"10.1073\/pnas.171310498","article-title":"Polar targeting of Shigella virulence factor IcsA in Enterobacteriacae and Vibrio","volume":"98","author":"Charles","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jim.2025.113905_bb0045","series-title":"Essentials of Veterinary Immunology and Immunopathology","first-page":"253","article-title":"Immunopathology of Diarrhea in animals","author":"Chauhan","year":"2024"},{"issue":"44","key":"10.1016\/j.jim.2025.113905_bb0050","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1016\/j.vaccine.2016.08.034","article-title":"Development of recombinant vaccine candidate molecule against Shigella infection","volume":"34","author":"Chitradevi","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2025.113905_bb0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0076-6879(86)18114-6","article-title":"ELISA techniques","volume":"118","author":"Clark","year":"1986","journal-title":"Methods Enzymol."},{"issue":"5","key":"10.1016\/j.jim.2025.113905_bb0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/vaccines10050675","article-title":"Detoxified O-specific polysaccharide (O-SP)\u2013protein conjugates: emerging approach in the Shigella Vaccine development scene","volume":"10","author":"Cohen","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-023-00797-6","article-title":"Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate","volume":"9","author":"Desalegn","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jim.2025.113905_bb0070","series-title":"Molecular Medical Microbiology","first-page":"1045","author":"Diarrheagenic","year":"2024"},{"issue":"6","key":"10.1016\/j.jim.2025.113905_bb0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a116134","article-title":"Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile","volume":"134","author":"Ferreccio","year":"1991","journal-title":"Am. J. Epidemiol."},{"issue":"sup3","key":"10.1016\/j.jim.2025.113905_bb0080","doi-asserted-by":"crossref","DOI":"10.1080\/21691401.2018.1529676","article-title":"EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7","volume":"46","author":"Hajizade","year":"2018","journal-title":"Artif Cells Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0085","doi-asserted-by":"crossref","first-page":"22484","DOI":"10.1038\/s41598-024-73105-4","article-title":"A multi-epitope protein vaccine encapsulated in alginate nanoparticles as a candidate vaccine against Shigella sonnei","volume":"14","author":"Hashemi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jim.2025.113905_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112316","article-title":"Mesoporous silica nanoparticles-based formulations of a chimeric proteinous vaccine candidate against necrotic enteritis disease","volume":"128","author":"Hoseini","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0095","first-page":"159","article-title":"Immunogenicity evaluation of recombinant Staphylococcus aureus enterotoxin B (rSEB) and rSEB-loaded chitosan nanoparticles following nasal administration","volume":"19","author":"Hosseini","year":"2020","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1773-2247(14)50005-6","article-title":"Novel intranasal vaccine delivery system by chitosan nanofibrous membrane containing N-terminal region of IpaD antigen as a nasal shigellosis vaccine, studies in Guinea pigs","volume":"24","author":"Jahantigh","year":"2014","journal-title":"J Drug Deliv Sci Technol."},{"issue":"31","key":"10.1016\/j.jim.2025.113905_bb0105","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.vaccine.2018.06.037","article-title":"Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis","volume":"36","author":"Jarz\u0105b","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2025.113905_bb0110","doi-asserted-by":"crossref","first-page":"1340425","DOI":"10.3389\/fimmu.2024.1340425","article-title":"Age-dependent acquisition of IgG antibodies to Shigella serotypes\u2014a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination","volume":"15","author":"Kapulu","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jim.2025.113905_bb0115","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.chom.2013.04.012","article-title":"The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection","volume":"13","author":"Kobayashi","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.jim.2025.113905_bb0120","first-page":"517","article-title":"An LTB-entrapped protein in PLGA nanoparticles preserves against enterotoxin of enterotoxigenic Escherichia coli","volume":"21","author":"Kordbacheh","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.jim.2025.113905_bb0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molimm.2019.09.015","article-title":"Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. Coli O157: H7","volume":"114","author":"Kordbacheh","year":"2019","journal-title":"Mol. Immunol."},{"issue":"15","key":"10.1016\/j.jim.2025.113905_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/aem.00384-22","article-title":"Characterization of functional B-cell epitopes at the amino terminus of Shigella invasion plasmid antigen B (IpaB)","volume":"88","author":"Li","year":"2022","journal-title":"Appl. Environ. Microbiol."},{"issue":"Suppl. 1","key":"10.1016\/j.jim.2025.113905_bb0135","first-page":"S1","article-title":"Editors. The Enterics for Global Health (EFGH) Shigella surveillance study in Peru","volume":"11","author":"Manzanares Villanueva","year":"2024","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.jim.2025.113905_bb0140","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/IAI.06174-11","article-title":"Broadly protective Shigella vaccine based on type III secretion apparatus proteins","volume":"80","author":"Martinez-Becerra","year":"2012","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.jim.2025.113905_bb0145","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1128\/IAI.00859-13","article-title":"Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine","volume":"81","author":"Martinez-Becerra","year":"2013","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41541-020-0180-y","article-title":"A bivalent vaccine confers immunogenicity and protection against Shigella flexneri and enterotoxigenic Escherichia coli infections in mice","volume":"5","author":"Medeiros","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"3\u20134","key":"10.1016\/j.jim.2025.113905_bb0155","first-page":"251","article-title":"Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati)","volume":"43","author":"Meitert","year":"1984","journal-title":"Arch. Roum. Pathol. Exp. Microbiol."},{"issue":"21\u221222","key":"10.1016\/j.jim.2025.113905_bb0160","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(03)00111-7","article-title":"Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition","volume":"21","author":"Mukhopadhaya","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jim.2025.113905_bb0165","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.coph.2009.10.004","article-title":"The role of neutrophils in the event of intestinal inflammation","volume":"9","author":"Mumy","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.52547\/vacres.8.1.18","article-title":"Design and recombinant expression of a multiepitope Vaccine candidate against pathogenic species of Shigella","volume":"8","author":"Namvar","year":"2021","journal-title":"Vaccine Res."},{"issue":"4","key":"10.1016\/j.jim.2025.113905_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00260-18","article-title":"A novel Shigella proteome microarray discriminates targets of human antibody reactivity following oral vaccination and experimental challenge","volume":"3","author":"Ndungo","year":"2018","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0180","first-page":"133","article-title":"Shigellosis","volume":"43","author":"Niyogi","year":"2005","journal-title":"J. Microbiol."},{"key":"10.1016\/j.jim.2025.113905_bb0185","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2019.09.018","article-title":"Designing a multi-epitope vaccine for cross-protection against Shigella spp: an immunoinformatics and structural vaccinology study","volume":"116","author":"Nosrati","year":"2019","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/iai.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.","volume":"53","author":"Oaks","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jim.2025.113905_bb0195","series-title":"Disease Outbreak News","article-title":"Extensively drug-resistant Shigella sonnei infections\u2014Europe\u2014European Region (EURO)","author":"Organization WH","year":"2022"},{"issue":"46","key":"10.1016\/j.jim.2025.113905_bb0200","doi-asserted-by":"crossref","first-page":"E4345","DOI":"10.1073\/pnas.1303641110","article-title":"Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation","volume":"110","author":"Paciello","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mib.2008.12.002","article-title":"Shigella type III secretion effectors: how, where, when, for what purposes?","volume":"12","author":"Parsot","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"issue":"23","key":"10.1016\/j.jim.2025.113905_bb0210","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.3390\/ijms21239254","article-title":"Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells","volume":"21","author":"Pietrzak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jim.2025.113905_bb0215","series-title":"A Short History of Vaccination. Vaccines","first-page":"1","author":"Plotkin","year":"2012"},{"issue":"36","key":"10.1016\/j.jim.2025.113905_bb0220","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/j.vaccine.2013.05.100","article-title":"Outer membrane protein a (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate","volume":"31","author":"Pore","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0225","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/ijms23020994","article-title":"Shigella outer membrane vesicles as promising targets for vaccination","volume":"23","author":"Qasim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jim.2025.113905_bb0230","doi-asserted-by":"crossref","first-page":"1361610","DOI":"10.3389\/fgene.2024.1361610","article-title":"Designing a multi-epitope vaccine against Shigella dysenteriae using immuno-informatics approach","volume":"15","author":"Qureshi","year":"2024","journal-title":"Front. Genet."},{"key":"10.1016\/j.jim.2025.113905_bb0235","first-page":"15","article-title":"Shigella pathogenesis: new insights through advanced methodologies","author":"Schnupf","year":"2019","journal-title":"Bacteria Intracellularity"},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0240","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CMR.00032-07","article-title":"Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion","volume":"21","author":"Schroeder","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.jim.2025.113905_bb0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/1871526523666230811093114","article-title":"A review on the antibiotic resistance of Shigella strains in Iran","volume":"24","author":"Shooraj","year":"2024","journal-title":"Infect. Disord. Drug Targets"},{"issue":"12","key":"10.1016\/j.jim.2025.113905_bb0250","article-title":"Identification and analysis of immunoreactive proteins of Shigella flexneri in human sera and stool specimens","volume":"28","author":"Singh","year":"2024","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.jim.2025.113905_bb0255","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/icb.1997.63","article-title":"Multi-epitope DNA vaccines","volume":"75","author":"Suhrbier","year":"1997","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.jim.2025.113905_bb0260","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1473-3099(22)00879-9","article-title":"Genomic reconstruction and directed interventions in a multidrug-resistant shigellosis outbreak in Seattle, WA, USA: a genomic surveillance study","volume":"23","author":"Tansarli","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"24","key":"10.1016\/j.jim.2025.113905_bb0265","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00363-20","article-title":"Influence of Shigella flexneri 2a O antigen acetylation on its bacteriophage Sf6 receptor activity and bacterial interaction with human cells","volume":"202","author":"Teh","year":"2020","journal-title":"J. Bacteriol."},{"issue":"6","key":"10.1016\/j.jim.2025.113905_bb0270","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S1473-3099(22)00807-6","article-title":"Emergence of extensively drug-resistant and multidrug-resistant Shigella flexneri serotype 2a associated with sexual transmission among gay, bisexual, and other men who have sex with men, in England: a descriptive epidemiological study","volume":"23","author":"Thorley","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1574-695X.2006.00137.x","article-title":"Enterobacterial 38-kDa outer membrane protein is an age-dependent molecular marker of innate immunity and immunoglobulin deficiency as results from its reactivity with IgG and IgA antibody","volume":"48","author":"Witkowska","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.jim.2025.113905_bb0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/infdis\/jit399","article-title":"A mouse model of shigellosis by intraperitoneal infection","volume":"209","author":"Yang","year":"2014","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217592500105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002217592500105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:45:24Z","timestamp":1776833124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002217592500105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"alternative-id":["S002217592500105X"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2025.113905","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in-silico-designed multiepitope vaccine candidate can efficiently protect mice against pathogenic species of Shigella","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2025.113905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113905"}}